S
Shaun Jordan
Researcher at Otsuka Pharmaceutical
Publications - 31
Citations - 1047
Shaun Jordan is an academic researcher from Otsuka Pharmaceutical. The author has contributed to research in topics: Partial agonist & Aripiprazole. The author has an hindex of 13, co-authored 31 publications receiving 1015 citations.
Papers
More filters
Journal ArticleDOI
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.
TL;DR: Aripiprazole is the first dopamine-serotonin system stabilizer, according to a study demonstrating potent, partial agonism at 5-HT(1A) receptors in a guanosine-5'-O-(3-[( 35)S]thio)-triphosphate ([(35)S)GTP gamma S)-binding assay.
Journal ArticleDOI
Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors: functional receptor-binding and in vivo electrophysiological studies
Arlene Stark,Shaun Jordan,Kelly A. Allers,Robert L. Bertekap,Ruoyan Chen,Tanaz Mistry Kannan,Thaddeus F. Molski,Frank D. Yocca,Trevor Sharp,Tetsuro Kikuchi,Kevin D. Burris +10 more
TL;DR: Results support a partial agonist activity for aripiprazole at 5-HT1A receptors in vitro and in vivo, and suggest important interactions with other 4-HT-receptor subtypes and this receptor activity profile may contribute to the antipsychotic activity of aripine in humans.
Journal ArticleDOI
In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function.
TL;DR: In vivo microdialysis data provide in vivo evidence of aripiprazole-induced changes in forebrain dopaminergic and serotonergic function that may reflect its partial agonist activity at presynaptic dopamine D(2) and 5-HT(1A) receptors and antagonist activity at 5-HIAA receptors.
Journal ArticleDOI
Aripiprazole: A dopamine-serotonin system stabilizer
Patent
5-HT1A Receptor Subtype Agonist
TL;DR: In this article, a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT 1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof, was described.